A medical breakthrough is shining a light on the biotech's promising development platform.Shares of Praxis Precision Medicines (PRAX +13.25%) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor treatment. By the close of trading, Praxis' stock price was up more than 13%. A promising development Praxis specializes in using genetic insights to discover new therapies for neurological disorders. The biotech's efforts r ...